Parkside Financial Bank & Trust Ironwood Pharmaceuticals Inc Transaction History

Parkside Financial Bank & Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$5.58 - $8.61 $362 - $559	65 Added 433.33%	80 $0
Q1 2024 May 01, 2024	BUY	$8.32 - $15.45 $124 - $231	15 New	15 $0
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $957 - $1,316	116 Added 773.33%	131 $1,000
Q2 2023 Aug 15, 2023	SELL	$10.1 - $11.6 $10 - $11	-1 Reduced 6.25%	15 $0
Q1 2023 May 04, 2023	SELL	$10.37 - $12.56 $103 - $125	-10 Reduced 38.46%	16 $0
Q3 2022 Nov 01, 2022	BUY	$10.14 - $12.38 $152 - $185	15 Added 136.36%	26 $0
Q2 2022 Jul 13, 2022	BUY	$11.05 - $12.72 $121 - $139	11 New	11 $0

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.